Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31
Tweet
Share
E-mail
http://archive.fast-edgar.com/20160314/AVK2B22CZ222V2Z2222D22ZWJSFCYQ222282
Filed on: March 14, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach
- Findem Launches Studio: People Intelligence, Built for AI, That Returns Finished Work Teams Can Trust
- 3 E Network Develops Multi-Megawatt Green Energy Architecture for Finnish AI Data Center
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
